Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

President’s Perspective: The ACR and ARHP Advance Rheumatology Through International Collaboration

Audrey B. Uknis, MD, and Jan K. Richardson, PT, PhD, OCS  |  August 1, 2013

By forging new connections and strengthening efforts with global organizations such as EULAR, the College hopes to enhance the science, clinical care, and perceived value of rheumatology

Why I Advocate for Arthritis: A Patient’s Perspective

Rev. Anthony J. Hillelson  |  August 1, 2013

Reverend Anthony J. Hillelson, who has rheumatoid arthritis, on why he lobbies Congress to support rheumatic disease research funding

ACR 2013 State-of-the-Art Clinical Symposium: How to Identify Signs of Myositis and Metabolic Myopathies

Kathy Holliman  |  August 1, 2013

Rheumatologists offer tips for diagnosing and treating these diseases

ACR 2013 State-of-the-Art Clinical Symposium: What’s Next in Therapy for Osteoarthritis, Rheumatoid Arthritis, and Lupus?

Kathy Holliman  |  August 1, 2013

Experts highlight treatment advances and challenges ahead in OA, RA, and systemic lupus erythematosus (SLE)

ACR 2013 State-of-the-Art Clinical Symposium: Diagnosis and Management of Vasculitis

Kathy Holliman  |  August 1, 2013

The latest on Behçet’s syndrome, infectious arthritis, and central nervous system vasculitis

Healthcare Providers Must Get Compliant with HIPAA Privacy Practices

Steven M. Harris, Esq.  |  August 1, 2013

Failure to have an updated Notice of Privacy Practices by September 23, 2013 could result in fines and penalties

New Methodology to Improve Cartilage Repair

Lara C. Pullen, PhD  |  July 31, 2013

A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells.  (posted July 31, 2013)

B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis

Lara C. Pullen, PhD  |  July 31, 2013

Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)

Congress Considers More Regulation for Manufacturers of Compounding Drugs

Richard Quinn  |  July 22, 2013

New legislation would place manufacturers of compounding drugs under FDA supervision. (posted July 22, 2013)

President’s Perspective: Will the Physician Payment Sunshine Act Shed Light on Conflicts of Interest?

Audrey B. Uknis, MD  |  July 1, 2013

What rheumatologists should know about complying with the PPSA when it goes into effect on August 1

  • « Previous Page
  • 1
  • …
  • 239
  • 240
  • 241
  • 242
  • 243
  • …
  • 308
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences